Glycogen synthase kinase 3: A point of integration in alzheimer's disease and a therapeutic target?

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Mondragón Rodríguez, Siddhartha ^a   Perry, George ^b,c   Zhu, Xiongwei ^c   Moreira, Paula I ^d,e   Williams, Sylvain ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; TAU PROTEIN;

ALZHEIMER DISEASE; HUMAN; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW;

EID: 84863697825     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/276803     Document Type: Review

References (47)

1. Wu D., Pan W., GSK3: a multifaceted kinase in Wnt signaling Trends in Biochemical Sciences 2010 35 3 161 168
2. Metcalfe C., Bienz M., Inhibition of GSK3 by Wnt signallingtwo contrasting models Journal of Cell Science 2011 124 21 3537 3544
3. Taelman V. F., Dobrowolski R., Plouhinec J. L., Fuentealba L. C., Vorwald P. P., Gumper I., Sabatini D. D., De Robertis E. M., Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes Cell 2010 143 7 1136 1148
4. Papkoff J., Aikawa M., WNT-1 and HGF regulate GSK3 activity and -catenin signaling in mammary epithelial cells Biochemical and Biophysical Research Communications 1998 247 3 851 858 (Pubitemid 28418480)
5. Saito Y., Vandenheede J. R., Cohen P., The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells Biochemical Journal 1994 303 1 27 31 (Pubitemid 24302894)
6. Cross D. A. E., Alessi D. R., Vandenheede J. R., McDowell H. E., Hundal H. S., Cohen P., The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf Biochemical Journal 1994 303 1 21 26 (Pubitemid 24302893)
7. Sutherland C., Leighton I. A., Cohen P., Inactivation of glycogen synthase kinase-3 by phosphorylation: new kinase connections in insulin and growth-factor signalling Biochemical Journal 1993 296 1 15 19 (Pubitemid 23344723)
8. Stambolic V., Woodgett J. R., Mitogen inactivation of glycogen synthase kinase-3 in intact cells via serine 9 phosphorylation Biochemical Journal 1994 303 3 701 704 (Pubitemid 24325998)
9. Lochhead P. A., Kinstrie R., Sibbet G., Rawjee T., Morrice N., Cleghone V., A chaperone-dependent GSK3 transitional intermediate mediates activation-loop autophosphorylation Molecular Cell 2006 24 4 627 633 (Pubitemid 350284229)
10. Thornton T. M., Pedraza-Alva G., Deng B., Wood C. D., Aronshtam A., Clements J. L., Sabio G., Davis R. J., Matthews D. E., Doble B., Rincon M., Phosphorylation by p38 MAPK as an alternative pathway for GSK3 inactivation Science 2008 320 5876 667 670 (Pubitemid 351928349)
11. Wu G., Huang H., Abreu J. G., He X., Inhibition of GSK3 phosphorylation of -catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6 PLoS ONE 2009 4 3
12. Cadigan K. M., Liu Y. I., Wnt signaling: complexity at the surface Journal of Cell Science 2006 119 3 395 402
13. Frame S., Cohen P., Biondi R. M., A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation Molecular Cell 2001 7 6 1321 1327 (Pubitemid 32607364)
14. Woodgett J. R., Molecular cloning and expression of glycogen synthase kinase-3/factor A The EMBO Journal 1990 9 8 2431 2438
15. Mukai F., Ishiguro K., Sano Y., Fujita S. C., Aternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3 Journal of Neurochemistry 2002 81 5 1073 1083 (Pubitemid 34809290)
16. Al-Mulla F., Bitar M. S., Al-Maghrebi M., Behbehani A. I., Al-Ali W., Rath O., Doyle B., Tan K. Y., Pitt A., Kolch W., Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3 Cancer Research 2011 71 4 1334 1343
17. Grimes C. A., Jope R. S., The multifaceted roles of glycogen synthase kinase 3 in cellular signaling Progress in Neurobiology 2001 65 4 391 426 (Pubitemid 32781670)
18. Soutar M. P. M., Kim W. Y., Williamson R., Peggie M., Hastie C. J., McLauchlan H., Snider W. D., Gordon-Weeks P. R., Sutherland C., Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain Journal of Neurochemistry 2010 115 4 974 983
19. Jope R. S., Roh M. S., Glycogen synthase kinase-3 (GSK3) in psychiatric disease and therapeutic interventions Current Drug Targets 2006 7 11 1421 1434 (Pubitemid 44718302)
20. Leroy K., Boutajangout A., Authelet M., Woodgett J. R., Anderton B. H., Brion J. P., The active form of glycogen synthase kinase-3 is associated with granulovacuolar degeneration in neurons in Alzheimers's disease Acta Neuropathologica 2002 103 2 91 99 (Pubitemid 36067485)
21. Johnson G. V. W., Hartigan J. A., Tau protein in normal and Alzheimer's disease brain: an update Journal of Alzheimer's Disease 1999 1 4-5 329 351
22. Farias G., Cornejo A., Jiménez J., Guzmn L., Maccioni R. B., Mechanisms of tau self-aggregation and neurotoxicity Current Alzheimer Research 2011 8 6 608 614
23. Johnson G. V. W., Stoothoff W. H., Tau phosphorylation in neuronal cell function and dysfunction Journal of Cell Science 2004 117 24 5721 5729 (Pubitemid 40123939)
24. Hanger D. P., Anderton B. H., Noble W., Tau phosphorylation: the therapeutic challenge for neurodegenerative disease Trends in Molecular Medicine 2009 15 3 112 119
25. Liu F., Li B., Tung E. J., Grundke-Iqbal I., Iqbal K., Gong C. X., Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation European Journal of Neuroscience 2007 26 12 3429 3436 (Pubitemid 350243526)
26. Mondragon-Rodriguez S. B.-I. G., Garca-Sierra F., The chronology and maturation of the neurofibrillary tangle pathology in Alzheimer's disease is based on the state of phosphorylation, conformational changes, and cleavage of tau protein. Novascience Book. In press
27. Mondragn-Rodrguez S., Basurto-Islas G., Santa-Maria I., Mena R., Binder L. I., Avila J., Smith M. A., Perry G., Garca-Sierra F., Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease International Journal of Experimental Pathology 2008 89 2 81 90 (Pubitemid 351365186)
28. Mondragn-Rodrguez S., Basurto-Islas G., Binder L. I., Garca-Sierra F., Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer's disease? Future Neurology 2009 4 1 39 53
29. Fischer D., Mukrasch M. D., Biernat J., Bibow S., Blackledge M., Griesinger C., Mandelkow E., Zweckstetter M., Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules Biochemistry 2009 48 42 10047 10055
30. Rankin C. A., Sun Q., Gamblin T. C., Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation Molecular Brain Research 2005 138 1 84 93 (Pubitemid 41032932)
31. Schaffer B. A. J., Bertram L., Miller B. L., Mullin K., Weintraub S., Johnson N., Bigio E. H., Mesulam M., Wiedau-Pazos M., Jackson G. R., Cummings J. L., Cantor R. M., Levey A. I., Tanzi R. E., Geschwind D. H., Association of GSK3B with Alzheimer disease and frontotemporal dementia Archives of Neurology 2008 65 10 1368 1374
32. Asuni A. A., Hooper C., Reynolds C. H., Lovestone S., Anderton B. H., Killick R., GSK3 exhibits -catenin and tau directed kinase activities that are modulated by Wnt European Journal of Neuroscience 2006 24 12 3387 3392 (Pubitemid 44952605)
33. Phiel C. J., Wilson C. A., Lee V. M. Y., Klein P. S., GSK-3 regulates production of Alzheimer's disease amyloid- peptides Nature 2003 423 6938 435 439 (Pubitemid 36626994)
34. Kaytor M. D., Orr H. T., The GSK3 signaling cascade and neurodegenerative disease Current Opinion in Neurobiology 2002 12 3 275 278 (Pubitemid 34615752)
35. Jope R. S., Bijur G. N., Mood stabilizers, glycogen synthase kinase-3 and cell survival Molecular Psychiatry 2002 7 supplement 1 S35 S45
36. Chiu C. T., Chuang D. M., Neuroprotective action of lithium in disorders of the central nervous system Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011 36 6 461 476
37. Gravitz L., Drugs: a tangled web of targets Nature 2011 475 7355 S9 S11
38. Mondragn-Rodrguez S., Basurto-Islas G., Lee H.-G., Perry G., Zhu X., Castellani R. J., Smith M. A., Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis Expert Review of Neurotherapeutics 2010 10 5 683 691
39. Howland J. G., Wang Y. T., Synaptic plasticity in learning and memory: stress effects in the hippocampus Progress in Brain Research 2008 169 145 158 (Pubitemid 351451901)
40. Ho V. M., Lee J.-A., Martin K. C., The cell biology of synaptic plasticity Science 2011 334 6056 623 628
41. Collingridge G. L., Peineau S., Howland J. G., Wang Y. T., Long-term depression in the CNS Nature Reviews Neuroscience 2010 11 7 459 473
42. Appleby V. J., Corra S. A. L., Duckworth J. K., Nash J. E., Nol J., Fitzjohn S. M., Collingridge G. L., Molnr E., LTP in hippocampal neurons is associated with a CaMKII-mediated increase in GluA1 surface expression Journal of Neurochemistry 2011 116 4 530 543
43. Peineau S., Taghibiglou C., Bradley C., Wong T. P., Liu L., Lu J., Lo E., Wu D., Saule E., Bouschet T., Matthews P., Isaac J. T. R., Bortolotto Z., Wang Y. T., Collingridge G. L., LTP inhibits LTD in the hippocampus via regulation of GSK3beta Neuron 2007 53 5 703 717 (Pubitemid 46283369)
44. Kwok J. B., Loy C. T., Hamilton G., Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease Annals of Neurology 2008 64 4 446 454
45. Zhang N., Yu J. T., Yang Y., Yang J., Zhang W., Tan L., Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese Brain Research 2011 1391 147 153
46. Massoud F., Leger G. C., Pharmacological treatment of Alzheimer disease Canadian Journal of Psychiatry 2011 56 10 579 588
47. Hernndez F., Langa E., Cuadros R., Avila J., Villanueva N., Regulation of GSK3 isoforms by phosphatases PP1 and PP2A Molecular and Cellular Biochemistry 2010 344 1-2 211 215